Image de couverture de livre

Bayesian Safety and Futility Monitoring in Phase II Trials Using One Utility‐Based Rule

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Juhee Lee, Peter F. Thall
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	Statistics in Medicine
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Futility Monitoring in Clinical Trials
par: Ana M. Ortega‐Villa, et autres
Publié: (2025)

BAR12 : Bayesian Autoregressive Phase 1‐2 Design for Cell Therapy Trials With Manufacturing Changes
par: Cheng‐Han Yang, et autres
Publié: (2026)

Informative Futility Rules Based on Conditional Assurance
par: Vladimir Dragalin
Publié: (2026)

The Whys, Whens, and Hows of Futility Monitoring
par: Karen M. Higgins, et autres
Publié: (2025)

Futility Analyses for the MCP ‐Mod Methodology Based on Longitudinal Models
par: Björn Bornkamp, et autres
Publié: (2025)

The Win Ratio Approach in Bayesian Monitoring for Two‐Arm Phase II Clinical Trial Designs With Multiple Time‐To‐Event Endpoints
par: Xinran Huang, et autres
Publié: (2024)

Defining Utility as a Measure of Preference Under Uncertainty in Phase I– II Oncology Dose Finding Trials
par: Andrew Hall, et autres
Publié: (2026)

A Bayesian Treatment Selection Design for Phase II Randomised Cancer Clinical Trials
par: Moka Komaki, et autres
Publié: (2026)

Bayesian Ordered Lattice Design for Phase I Clinical Trials
par: Gi‐Ming Wang, et autres
Publié: (2026)

Adaptive Biomarker‐Based Design for Early Phase Clinical Trials
par: Alessandra Serra, et autres
Publié: (2025)

Dose Individualization for Phase I Cancer Trials With Broadened Eligibility
par: Rebecca B. Silva, et autres
Publié: (2024)

Bayesian Prediction of Event Times Using Mixture Model for Blinded Randomized Controlled Trials
par: Jingyan Fu, et autres
Publié: (2025)

Specification of Estimands for Complex Disease Processes Using Multistate Models and Utility Functions
par: Alexandra Bühler, et autres
Publié: (2025)

A Generalized Phase I/II Dose Optimization Trial Design With Multi‐Categorical and Multi‐Graded Outcomes
par: Yichen Yan, et autres
Publié: (2025)

Design and Analysis of N‐Of‐1 Trials That Incorporate Sequential Monitoring
par: Shu Jiang, et autres
Publié: (2025)

Bayesian Response‐Adaptive Randomization for Cluster Randomized Controlled Trials
par: Yunyi Liu, et autres
Publié: (2026)

Safety‐Driven Response Adaptive Randomization: An Application in Noninferiority Oncology Trials
par: Maria Vittoria Chiaruttini, et autres
Publié: (2026)

Sequential Monitoring of Covariate‐Adaptive Randomized Clinical Trials With Non‐Parametric Approaches
par: Xiaotian Chen, et autres
Publié: (2025)

Comments on “Novel Non‐Linear Models for Clinical Trial Analysis With Longitudinal Data: A Tutorial Using SAS for Both Frequentist and Bayesian Methods”
par: M. C. Donohue, et autres
Publié: (2025)

Bayesian Network Meta‐Analysis With One or Two Continuous Outcomes Measured at Multiple Time Points Using Gaussian Random Walks With Drift
par: Pai‐Shan Cheng, et autres
Publié: (2026)

Synergy Area With FDR ‐Controlled Evaluation ( SAFE ) to Robustly Assess Safety Profile in Clinical Trials
par: Tianyu Zhan, et autres
Publié: (2026)

Using Propensity Score Weighting With Clustered Data When the Treatment Is Applied at the Level of the Cluster and Outcomes Are Assessed at the Level of the Individual: The Observational Analog of Cluster Randomization Trials
par: Peter C. Austin
Publié: (2026)

Accounting for Carryover Toxicity in Phase I Clinical Trials with Intra‐Patient Dose Escalation
par: Chloe E. Falke, et autres
Publié: (2025)

Response to Letter to the Editor “Comments on ‘Novel Non‐Linear Models for Clinical Trial Analysis With Longitudinal Data: A Tutorial Using SAS for Both Frequentist and Bayesian Methods’”
par: Guoqiao Wang, et autres
Publié: (2025)

Bayesian Power Prior in Platform Trials With Non‐Concurrent Control for Binary Outcomes: Development and Comparative Evaluation
par: Junichi Asano, et autres
Publié: (2026)

Confidence Intervals for Adaptive Trial Designs II : Case Study and Practical Guidance
par: David S. Robertson, et autres
Publié: (2025)

Tutorial on Bayesian Functional Regression Using Stan
par: Ziren Jiang, et autres
Publié: (2025)

Clinical Trial Simulation: Planning With the OCTAVE Framework, Implementation and Validation Principles
par: Kim May Lee, et autres
Publié: (2026)

Using Win Odds to Improve Commit‐to‐Phase‐3 Decision‐Making in Oncology
par: Benjamin F. Hartley, et autres
Publié: (2025)

Cumulative Logit Ordinal Regression With Proportional Odds Under Nonignorable Missing Responses—Application to Phase III Trial
par: Arnab Kumar Maity, et autres
Publié: (2025)

Exact Randomized Two‐Stage Phase 2 Clinical Trial Designs for Two Binary Co‐Primary Endpoints
par: Hyejung Jung, et autres
Publié: (2026)

Adaptive Seamless Phase II / III Randomization Test Considering Treatment Group Selection Based on Short–Term Binary Outcomes
par: Funato Sato, et autres
Publié: (2026)

On Inclusion of Covariates in Model Based Dose Finding Clinical Trial Designs
par: Adrien Ollier, et autres
Publié: (2025)

A Biomarker‐Based Dose–Schedule Optimization Design for Immunotherapy Trials
par: Yingjie Qiu, et autres
Publié: (2026)

Sample Size Calculation in Dose Optimization Trials Using the Margin of Practical Non‐Inferiority
par: Hakim‐Moulay Dehbi, et autres
Publié: (2025)

Group Sequential Trial Design Using Stepwise Monte Carlo for Increased Flexibility and Robustness
par: Amitay Kamber, et autres
Publié: (2025)

Analysis of Stepped‐Wedge Cluster Randomized Trials: A Tutorial Using Marginal Models
par: Elizabeth L. Turner, et autres
Publié: (2026)

A Partially Randomized Patient Preference, Sequential, Multiple‐Assignment, Randomized Trial Design Analyzed via Weighted and Replicated Frequentist and Bayesian Methods
par: Marianthie Wank, et autres
Publié: (2024)

Negative Control Outcome Adjustment in Early‐Phase Randomized Trials: Estimating Vaccine Effects on Immune Responses in HIV Exposed Uninfected Infants
par: Ethan Ashby, et autres
Publié: (2025)

Improved Pharmacovigilance Signal Detection Using Bayesian Generalized Linear Mixed Models
par: Paloma Hauser, et autres
Publié: (2025)